Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD 2.460
-0.070 (-2.77%)
May 7, 2026, 4:10 PM AEST
Vita Life Sciences Market Cap
Vita Life Sciences has a market cap or net worth of 133.65 million as of May 7, 2026. Its market cap has increased by 35.71% in one year.
Market Cap
133.65M
Enterprise Value
100.39M
Revenue
93.27M
Ranking
n/a
PE Ratio
13.41
Stock Price
2.46
Market Cap Chart
Since August 23, 2007, Vita Life Sciences's market cap has increased from 2.18M to 133.65M, an increase of 6,023.01%. That is a compound annual growth rate of 24.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 133.65M | -5.16% |
| Dec 31, 2025 | 140.92M | 26.53% |
| Dec 31, 2024 | 111.37M | 16.19% |
| Dec 27, 2023 | 95.85M | 25.15% |
| Dec 21, 2022 | 76.59M | -26.95% |
| Dec 31, 2021 | 104.86M | 93.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medical Developments International | 52.95M |
| Syntara | 45.76M |
| Little Green Pharma | 29.97M |
| Vitura Health | 24.52M |
| Peak Processing | 20.89M |
| IDT Australia | 17.95M |
| Cann Group | 8.06M |
| Epsilon Healthcare | 7.78M |